• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Efficacy of urate oxidase (uricozyme) in tumour lysis induced urate nephropathy.

作者信息

Leach M, Parsons R M, Reilly J T, Winfield D A

机构信息

Department of Haematology, Royal Hallamshire Hospital, Sheffield, UK.

出版信息

Clin Lab Haematol. 1998 Jun;20(3):169-72. doi: 10.1046/j.1365-2257.1998.00124.x.

DOI:10.1046/j.1365-2257.1998.00124.x
PMID:9681232
Abstract

Urate oxidase (uricozyme) is an enzyme of non-human origin capable of oxidizing human uric acid to allantoin, a highly soluble product at renal tubule pH. We report its efficacy in three patients with acute urate nephropathy due to tumour lysis in chronic lymphatic leukaemia and high grade lymphoma. Two patients had an additional obstructive nephropathy due to ureteric urate crystals. An intravenous infusion (100 units/kg in 50 ml saline over 30 min) was given for between two and five consecutive days. All patients showed a rapid fall in serum urate levels with associated diuresis, correction of metabolic disturbance and full resolution of uraemia within a week. The treatment was well tolerated and caused a rapid resolution of clinical symptoms in all cases. We review the literature relating to the use of this agent both in the treatment of hyperuricaemic acute renal failure and gouty arthritis.

摘要

相似文献

1
Efficacy of urate oxidase (uricozyme) in tumour lysis induced urate nephropathy.
Clin Lab Haematol. 1998 Jun;20(3):169-72. doi: 10.1046/j.1365-2257.1998.00124.x.
2
Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies.尿酸氧化酶在预防和治疗与淋巴系统恶性肿瘤相关的高尿酸血症中的应用
Leukemia. 1997 Nov;11(11):1813-6. doi: 10.1038/sj.leu.2400850.
3
Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer.尿酸氧化酶用于预防和治疗患癌儿童的肿瘤溶解综合征。
Cochrane Database Syst Rev. 2014 Aug 14(8):CD006945. doi: 10.1002/14651858.CD006945.pub3.
4
Recurrent chemotherapy-induced tumor lysis syndrome (TLS) with renal failure in a patient with chronic lymphocytic leukemia - successful treatment and prevention of TLS with low-dose rasburicase.慢性淋巴细胞白血病患者复发性化疗诱导的肿瘤溶解综合征(TLS)伴肾衰竭——低剂量拉布立酶成功治疗和预防TLS
Eur J Haematol. 2005 Dec;75(6):518-21. doi: 10.1111/j.1600-0609.2005.00550.x.
5
Prevention of urate nephropathy in the tumour lysis syndrome.
Clin Lab Haematol. 1989;11(2):97-100. doi: 10.1111/j.1365-2257.1989.tb00189.x.
6
European experience in the treatment of hyperuricemia.欧洲高尿酸血症治疗经验。
Semin Hematol. 2001 Oct;38(4 Suppl 10):9-12. doi: 10.1016/s0037-1963(01)90038-1.
7
Management of hyperuricemia with rasburicase review.拉布立酶治疗高尿酸血症的综述
Nucleosides Nucleotides Nucleic Acids. 2004 Oct;23(8-9):1431-40. doi: 10.1081/NCN-200027656.
8
Hyperuricemia and urate nephropathy in urate oxidase-deficient mice.尿酸氧化酶缺陷小鼠的高尿酸血症和尿酸盐肾病
Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):742-6. doi: 10.1073/pnas.91.2.742.
9
Urate oxidase for the prevention and treatment of tumor lysis syndrome in children with cancer.尿酸氧化酶用于预防和治疗患癌儿童的肿瘤溶解综合征。
Cochrane Database Syst Rev. 2010 Jun 16(6):CD006945. doi: 10.1002/14651858.CD006945.pub2.
10
Elitek-rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002.精英型重组尿酸氧化酶:预防和治疗与肿瘤溶解综合征相关的高尿酸血症的有效手段,会议报告,得克萨斯州达拉斯,2002年1月
Leukemia. 2003 Mar;17(3):499-514. doi: 10.1038/sj.leu.2402847.

引用本文的文献

1
The Relationship Between Serum Uric Acid at Different Concentrations of Lipid Indices and the Risk of Myocardial Revascularization in Patients With Acute Coronary Syndrome: A Retrospective Analysis.急性冠状动脉综合征患者不同血脂指标浓度下血清尿酸与心肌血运重建风险的关系:一项回顾性分析
Front Cardiovasc Med. 2021 Aug 23;8:732715. doi: 10.3389/fcvm.2021.732715. eCollection 2021.
2
Uric acid preconditioning alleviated doxorubicin induced JNK activation and Cx43 phosphorylation associated cardiotoxicity via activation of AMPK-SHP2 signaling pathway.尿酸预处理通过激活AMPK-SHP2信号通路减轻阿霉素诱导的JNK激活和Cx43磷酸化相关的心脏毒性。
Ann Transl Med. 2020 Dec;8(23):1570. doi: 10.21037/atm-20-3105.
3
Lowering serum urate does not improve endothelial function in patients with type 2 diabetes.
降低血清尿酸并不能改善2型糖尿病患者的内皮功能。
Diabetologia. 2007 Dec;50(12):2572-9. doi: 10.1007/s00125-007-0817-7. Epub 2007 Oct 10.
4
Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout.拉布立酶是治疗肿瘤溶解综合征和痛风患者高尿酸血症的一种新工具。
Int J Med Sci. 2007 Mar 2;4(2):83-93. doi: 10.7150/ijms.4.83.
5
Rasburicase prevents tumor lysis syndrome despite extreme hyperleukocytosis.尽管存在极度白细胞增多症,拉布立酶仍可预防肿瘤溶解综合征。
Pediatr Nephrol. 2004 Aug;19(8):924-7. doi: 10.1007/s00467-004-1524-y. Epub 2004 Jun 4.